LON:IBT International Biotechnology (IBT) Share Price, News & Analysis GBX 546 +10.00 (+1.87%) As of 04/17/2025 11:50 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About International Biotechnology Stock (LON:IBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBT alerts:Sign Up Key Stats Today's Range 540▼ 54850-Day Range 480▼ 72052-Week Range 480▼ 736Volume52,933 shsAverage Volume80,897 shsMarket Capitalization£196.13 millionP/E Ratio5.21Dividend Yield5.31%Price TargetN/AConsensus RatingN/A Company OverviewThe Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services. While the Company’s portfolio is held as one pool of assets, for operational purposes there is a quoted portfolio and an unquoted portfolio. The portfolio is diversified by geography, industry sub-sector and investment size with no single investment in a company normally accounting for more than 15% of the portfolio at the time of investment. The portfolio is split between large, mid and small-capitalisation companies, primarily quoted on stock exchanges in North America, where the most established and commercial biotech and other life sciences companies and companies operating in related sectors are based, though investments will also be made in Europe, Asia and Australia. Investments may also be made into unquoted companies and into funds not quoted on a stock exchange, including venture capital funds. This may include funds managed by the Investment Manager and/or members of its group. The primary purpose of investment in unquoted funds will be to gain exposure to unquoted companies. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Forward or derivative transactions are not used by the Company. The Company may borrow from time to time to exploit specific investment opportunities, rather than to apply long-term structural gearing to the Company’s portfolio of investments.Read More… Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News HeadlinesIntuitive BioTechnologies has Expanded Testing CapabilitiesFebruary 6, 2025 | tmcnet.comUpstream Bio, two other U.S. biotech startups price IPOs as healthcare listings riseOctober 11, 2024 | reuters.comTrump and Musk fight backIs there more to the Musk–Trump relationship than meets the eye? Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance. At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge.April 20, 2025 | Brownstone Research (Ad)Oxford BioDynamics Plc (OBD.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comPresentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV TherapySeptember 17, 2024 | markets.businessinsider.comUK firms fear tougher employment regulation, CBI saysSeptember 16, 2024 | reuters.comSan Jacinto College announces innovative biotechnology program to grow talent pipelineSeptember 16, 2024 | bizjournals.comBirmingham deemed “global leader in AI-driven biotech” by government officialSeptember 10, 2024 | bizjournals.comSee More Headlines IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? International Biotechnology's stock was trading at GBX 682 at the start of the year. Since then, IBT shares have decreased by 19.9% and is now trading at GBX 546. View the best growth stocks for 2025 here. How were International Biotechnology's earnings last quarter? International Biotechnology (LON:IBT) issued its quarterly earnings data on Tuesday, November, 5th. The company reported ($9.16) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a trailing twelve-month return on equity of 13.67%. How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP). Company Calendar Last Earnings11/05/2024Record date for 1/24 Dividend12/19/2024Ex-Dividend for 1/24 Dividend12/19/2024Dividend Payable1/24/2025Today4/20/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:IBT CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 104.80 Trailing P/E Ratio5.21 Forward P/E Ratio578.64 P/E GrowthN/ANet Income£37.91 million Net Margins90.66% Pretax MarginN/A Return on Equity13.67% Return on Assets3.57% Debt Debt-to-Equity Ratio8.09 Current RatioN/A Quick Ratio0.32 Sales & Book Value Annual Sales£41.82 million Price / Sales4.69 Cash FlowGBX 3.51 per share Price / Cash Flow155.74 Book ValueGBX 766.24 per share Price / Book0.71Miscellaneous Outstanding Shares35,921,299Free FloatN/AMarket Cap£196.13 million OptionableNot Optionable Beta0.21 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (LON:IBT) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.